Skip to main content

Table 4 CCR5-tropic virus predominates in the CSF and plasma in the majority of HIV-1+ individuals with varying degrees of neurocognitive impairment

From: Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope

Participant

Compartment

G2P CCR5

G2P CXCR4

PSSM CCR5

PSSM CXCR4

No Prediction

NCN1

CSF

7

0

7

0

0

 

Plasma

20

0

20

0

0

NCN2

CSF

29

0

29

0

0

 

Plasma

23

0

23

0

0

NCN3

CSF

26

0

26

0

0

 

Plasma

29

0

29

0

0

NCN4

CSF

35

0

35

0

0

 

Plasma

22

0

22

0

0

NCN5

CSF

28

0

28

0

0

 

Plasma

21

0

21

0

0

NCN6

CSF

18

0

18

0

0

 

Plasma

17

0

17

0

1 G2P + PSSM (Ins)

ANI1*

CSF

28

0

28

0

0

 

Plasma

23

2

23

2

0

ANI2*

CSF

20

0

20

0

0

 

Plasma

20

1

20

1

0

ANI3*

CSF

0

12

0

12

0

 

Plasma

1

16

1

16

0

ANI4

CSF

24

0

24

0

0

 

Plasma

40

0

41

0

1 G2P (Del)

ANI5

CSF

22

0

22

0

0

 

Plasma

19

0

19

0

0

ANI6

CSF

30

0

30

0

0

 

Plasma

27

0

28

0

1 G2P (Del)

ANI7*

CSF

31

0

29

2

0

 

Plasma

23

0

22

1

0

MND1

CSF

20

0

20

0

0

 

Plasma

26

0

26

0

0

MND2

CSF

26

0

26

0

0

 

Plasma

29

0

29

0

0

  1. The number of translated V3 loop sequences predicted to be CCR5 and CXCR4-tropic using both the Geno2Pheno (G2P) and the SINSI position-specific scoring matrix (PSSM) for all sequenced viral variants are shown. Three sequences yielded invalid predictions on co-receptor usage as a result of insertions (Ins) or deletions (Del) in the translated V3 loop sequence. Individuals for whom CXCR4-tropic variants are predicted in the CSF or plasma compartments are starred (*).